What another.vc does

another.vc is a European pre-seed and seed venture capital firm operating as another.vc GmbH, headquartered at Weseler Straße 35, 45478 Mülheim-Ruhr, Germany. The firm invests initial cheques of €100,000 in early-stage companies across three stated themes: AI Applications, Bio + Healthcare, and Frontier Tech, with visible deal flow across Germany, France and the broader EU. Its investment process is explicitly thesis-agnostic at the screening stage, relying on founder evaluation rather than market-size or checklist filters, and is differentiated on speed (single call to decision), a hands-off post-investment stance, and value-add concentrated in network access (first-believer positioning, first-customer introductions, future lead-investor hand-offs). The firm is led by Managing Directors Dr. Marius Alfs and Malte Scherff with team member Falk Haurenherm, and operates as a privately held GmbH (HRB 28070, Amtsgericht Duisburg) with 1–10 disclosed employees. The publicly visible portfolio spans Apheris (federated drug discovery), Comstruct (construction procurement data), Mimic (industrial robotics), Scoreplay (AI sports media), ATMOS Space Cargo (reusable spacecraft), Cleavr (AI accounts receivable) and Ark Climate (municipal climate software), with several assets having raised subsequent rounds (ATMOS Space Cargo €25.7M Series A, fonio.ai $17M, baCta €7M seed, Mimic $16M seed).

The firm's revenue mechanics follow standard venture fund economics: management fees on committed capital (and later, potential carried interest), with no disclosed AUM, fund size, or LP base. Distribution of capital to date is achieved through direct outreach plus a growing syndication network — visible co-investors across two recent deals alone include Satgana, Kima Ventures, Voyagers Climate Fund, Better Angle, Aonia Ventures, Super Capital, and strategic angels from Pennylane, Convelio, MyUnisoft and Mantu. another.vc has no proprietary technology product, SaaS platform, mobile app, API, or patent portfolio disclosed; its operating assets are its fund vehicles, brand, and partner relationships.

Name

another.vc

Legal name

another.vc GmbH

Website

https://another.vc

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

another.vc is a German pre-seed and seed venture capital firm writing €100k initial cheques into early-stage European startups across AI Applications, Bio + Healthcare, and Frontier Tech, led by Managing Directors Dr. Marius Alfs and Malte Scherff.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Micro-VC & Angel Funds (FSANAAAI)

akta.pro secondary industries

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD), Geography-Focused Venture Capital (Regional/Emerging Markets) (FSANAAAE)

Keywords

• Pre-seed venture capital
• Seed stage investing
• Early-stage funding
• AI applications investing
• Frontier tech venture

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others, Marketing or Sales, Technology or R&D

Core offering

another.vc is a venture capital firm that invests €100k as an initial check into pre-seed and seed stage founders across Europe. The firm focuses on AI Applications, Bio + Healthcare, and Frontier Tech sectors, offering capital alongside network access, introductions to future lead investors, and help landing early customers, delivered through a fast, conversation-driven process rather than a rigid investment thesis.

Product overview

another.vc is a venture capital firm (another.vc GmbH) headquartered in Mülheim-Ruhr, Germany. The firm provides early-stage investment services, offering an initial investment of €100k to founders. Their investment focus spans three areas: AI Applications, Bio + Healthcare, and Frontier Tech. The firm does not offer a technology product or software platform; rather, it offers investment capital, network access, and advisory support to portfolio companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Pre-seed and seed investment capital Initial €100k equity investment into pre-seed and seed stage European startups, with a stated focus on AI Applications, Bio + Healthcare, and Frontier Tech. Targets founders seeking an early-stage lead or co-lead investor with a fast decision process.
• Founder network and advisory support Ongoing hands-on support for portfolio founders, including introductions to future lead investors, help landing the first customer, and general network and experience support, provided without requiring formal engagement fees.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves5 records

Expansion highlights3 records

Market position

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments48 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about another.vc